LIPA and chronic obstructive pulmonary disease: Notably, Macro_SPP1 cells upregulated the lipid metabolism-related genes (e.g., PPARG, CD36, FABP5, LIPA, SREBF1, and SOAT1) in COPD airways, suggesting that they may undergo lipid metabolic reprogramming to drive their phenotypic and functional alterations.